{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:11:46Z","timestamp":1771009906676,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T00:00:00Z","timestamp":1156809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p>The system involving angiopoietin\u20102 (Ang\u20102) and its receptor, Tie\u20102, appears to play an important role not only in tumor angiogenesis, but also in the biology of haematological and non\u2010haematological malignancies. In the present study we evaluated the serum levels of soluble Ang\u20102 (sAng\u20102) and soluble Tie\u20102 (sTie\u20102) in patients with haematological malignancies. Measurements were carried out in 15 patients with chronic myeloid leukaemia (CML), 25 with essential thrombocythemia (ET), 24 with multiple myeloma (MM) and six with monoclonal gammopathy of undetermined significance (MGUS). In addition, we correlated the levels of angiopoietins with known prognostic factors. sAng\u20102 and sTie\u20102 were quantified with enzyme\u2010linked immunosorbent assay (ELISA). In patients with CML and MM the levels of sAng\u20102 were significantly higher (1686.53\u2003\u00b1\u2003936.41\u2003pg\/mL and 1917.82\u2003\u00b1\u20031427\u2003pg\/mL, respectively) than in controls (<jats:italic>n<\/jats:italic>\u2003=\u200315; 996.096\u2003\u00b1\u2003414.65\u2003pg\/mL) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). In patients with MM sAng\u20102 levels were significantly increased with increasing stage of disease, from stage I to stage III (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.03) and presented a trend of correlation with Beta2\u2010microglobulin levels (<jats:italic>r<\/jats:italic>\u2003=\u20030.317) and grade of bone involvement. Furthermore, the levels of sAng\u20102 determined after 6\u2003months of chemotherapy in CML patients were significantly lower than at diagnosis in the patients who achieved haematological remission. Circulating sTie\u20102 levels were increased in patients with ET (17.5\u2003\u00b1\u20039.2 vs 9\u2003\u00b1\u20033.5\u2003ng\/mL; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and in those with CML (16.29\u2003\u00b1\u20038.7\u2003ng\/mL; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.04). In conclusion, abnormal levels of sAng\u20102 and sTie\u20102 are present in some haematological malignancies. These markers may play a role in the pathophysiology of these conditions and their progression.<\/jats:p>","DOI":"10.1111\/j.0902-4441.2006.t01-1-ejh2795.x","type":"journal-article","created":{"date-parts":[[2006,9,15]],"date-time":"2006-09-15T14:38:43Z","timestamp":1158331123000},"page":"480-485","source":"Crossref","is-referenced-by-count":34,"title":["Differential levels of soluble angiopoietin\u20102 and Tie\u20102 in patients with haematological malignancies"],"prefix":"10.1111","volume":"77","author":[{"given":"E.","family":"Quartarone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alonci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Del Fabro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cincotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,9,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-2825-4_42"},{"key":"e_1_2_5_3_2","first-page":"1248","article-title":"Reciprocal paracrine interaction between tumor cells and endothelial cells: the \u00ab angiogenesis progression\u200a\u00bb hypothesis","volume":"36","author":"Rak J","year":"2000","journal-title":"Eur J Cancer"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00529-3"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/425778a"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02041"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0603-702"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.88.2.167"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.116.2.435"},{"key":"e_1_2_5_10_2","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar S\u2010V","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0960-135X.2004.01365.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2002.1"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.2002.2421"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.468"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1732989.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.172161899"},{"key":"e_1_2_5_17_2","first-page":"3403","article-title":"Tumor\u2010derived vascular endothelial growth factor up\u2010regulates angiopoietin\u20102 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer","volume":"63","author":"Zhang I","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_5_18_2","first-page":"113","article-title":"Expressions of vascular endothelial growth factor and angiopoietin\u20102 in myeloma cells","volume":"88","author":"Uneda S","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.125.4.725"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01243.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05932.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.07.004"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80665-2"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000022200.71892.9F"},{"key":"e_1_2_5_25_2","first-page":"196","article-title":"Overexpression of AKT2\/proteinkinase Beta leads to up\u2010regulation of Beta 1 integrins, increased invasion and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Arboleda MJ","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/10.8.1217"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm973"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00080.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200410"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00110-2"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64511-7"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2695"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2005.03.002"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4269"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3257"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214940"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65733-1"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.058"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.09.030"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0902-4441.2006.t01-1-EJH2795.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0902-4441.2006.t01-1-EJH2795.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T02:36:11Z","timestamp":1696991771000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0902-4441.2006.t01-1-EJH2795.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,28]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.0902-4441.2006.t01-1-EJH2795.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0902-4441.2006.t01-1-ejh2795.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,28]]}}}